146 related articles for article (PubMed ID: 11523022)
1. Cancer therapy. New strategies and treatment modalities for optimizing patient outcomes.
Gabrilove JL
Semin Hematol; 2001 Jul; 38(3 Suppl 7):1-7. PubMed ID: 11523022
[TBL] [Abstract][Full Text] [Related]
2. Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
Quirt I; Robeson C; Lau CY; Kovacs M; Burdette-Radoux S; Dolan S; Tang SC; McKenzie M; Couture F;
J Clin Oncol; 2001 Nov; 19(21):4126-34. PubMed ID: 11689580
[TBL] [Abstract][Full Text] [Related]
3. Comparable efficacy of epoetin alfa for anemic cancer patients receiving platinum- and nonplatinum-based chemotherapy: a retrospective subanalysis of two large, community-based trials.
Glaspy J; Degos L; Dicato M; Demetri GD
Oncologist; 2002; 7(2):126-35. PubMed ID: 11961196
[TBL] [Abstract][Full Text] [Related]
4. Predicting the hematopoietic response to recombinant human erythropoietin (Epoetin alfa) in the treatment of the anemia of cancer.
Adamson JW; Ludwig H
Oncology; 1999; 56(1):46-53. PubMed ID: 9885377
[TBL] [Abstract][Full Text] [Related]
5. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial.
Littlewood TJ; Bajetta E; Nortier JW; Vercammen E; Rapoport B;
J Clin Oncol; 2001 Jun; 19(11):2865-74. PubMed ID: 11387359
[TBL] [Abstract][Full Text] [Related]
6. Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.
Glaspy J; Bukowski R; Steinberg D; Taylor C; Tchekmedyian S; Vadhan-Raj S
J Clin Oncol; 1997 Mar; 15(3):1218-34. PubMed ID: 9060566
[TBL] [Abstract][Full Text] [Related]
7. The evolving role of epoetin alfa in cancer therapy.
Henry DH
Oncologist; 2004; 9(1):97-107. PubMed ID: 14755019
[TBL] [Abstract][Full Text] [Related]
8. The use of epoetin alfa to increase and maintain hemoglobin levels during radiotherapy.
Dunst J
Semin Oncol; 2001 Apr; 28(2 Suppl 8):42-8. PubMed ID: 11395852
[TBL] [Abstract][Full Text] [Related]
9. New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications.
Weiss MJ
Oncologist; 2003; 8 Suppl 3():18-29. PubMed ID: 14671225
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
Bieber E
J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
[TBL] [Abstract][Full Text] [Related]
11. Epoetin alfa in cancer patients: evidence-based guidelines.
Turner R; Anglin P; Burkes R; Couture F; Evans W; Goss G; Grimshaw R; Melosky B; Paterson A; Quirt I;
J Pain Symptom Manage; 2001 Nov; 22(5):954-65. PubMed ID: 11728799
[TBL] [Abstract][Full Text] [Related]
12. Epoetin alfa for the treatment of cancer- and chemotherapy-related anaemia: product review and update.
Henry DH
Expert Opin Pharmacother; 2005 Feb; 6(2):295-310. PubMed ID: 15757425
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with epoetin alfa in the management of hemoglobin levels in orthopedic surgery and cancer. Implications for use in gynecologic surgery.
Stovall TG
J Reprod Med; 2001 May; 46(5 Suppl):531-8. PubMed ID: 11396387
[TBL] [Abstract][Full Text] [Related]
14. The effect of Epoetin alfa on quality of life in anemic cancer patients.
Cella D; Bron D
Cancer Pract; 1999; 7(4):177-82. PubMed ID: 10687582
[TBL] [Abstract][Full Text] [Related]
15. Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study.
Abdelrazik N; Fouda M
Hematology; 2007 Dec; 12(6):533-41. PubMed ID: 17852440
[TBL] [Abstract][Full Text] [Related]
16. Once-weekly epoetin alfa for treating the anemia of chronic kidney disease.
Provenzano R; Garcia-Mayol L; Suchinda P; Von Hartitzsch B; Woollen SB; Zabaneh R; Fink JC;
Clin Nephrol; 2004 Jun; 61(6):392-405. PubMed ID: 15224803
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing.
Gabrilove JL; Cleeland CS; Livingston RB; Sarokhan B; Winer E; Einhorn LH
J Clin Oncol; 2001 Jun; 19(11):2875-82. PubMed ID: 11387360
[TBL] [Abstract][Full Text] [Related]
18. Epoetin alfa corrects anemia and improves quality of life in patients with hematologic malignancies receiving non-platinum chemotherapy.
Littlewood TJ; Nortier J; Rapoport B; Pawlicki M; de Wasch G; Vercammen E; Schuette W; Wils J; Freund M;
Hematol Oncol; 2003 Dec; 21(4):169-80. PubMed ID: 14735555
[TBL] [Abstract][Full Text] [Related]
19. Epoetin alfa improves quality of life in patients with cancer: results of metaanalysis.
Jones M; Schenkel B; Just J; Fallowfield L
Cancer; 2004 Oct; 101(8):1720-32. PubMed ID: 15386341
[TBL] [Abstract][Full Text] [Related]
20. Benefits associated with an early hemoglobin response to epoetin alfa therapy in the treatment of chemotherapy-related anemia.
Campos SM; Duh MS; Lefebvre P; Rosberg J
J Natl Compr Canc Netw; 2005 Nov; 3(6):807-16. PubMed ID: 16316616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]